Nantahala Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Quince Therapeutics, Inc. Common Stock, par value $0.001 per share (QNCX)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
Quince Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
QNCX
Shares outstanding
56,260,480 shares
Disclosed Ownership
5,620,422 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:32:11 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 10% 5,620,422 0 5,620,422 /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 10% 5,620,422 0 5,620,422 /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 10% 5,620,422 0 5,620,422 /s/ Daniel Mack Daniel Mack